Survival after prolonged pediatric extracorporeal membrane oxygenation support for adenoviral pneumonia. J Pediatr Surg 2008 Aug;43(8):e9-e11
Date
08/05/2008Pubmed ID
18675627DOI
10.1016/j.jpedsurg.2008.03.065Scopus ID
2-s2.0-48149109781 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Adenoviral pneumonia can cause significant pulmonary morbidity leading to extracorporeal membrane oxygenation (ECMO) rescue. Reported survival of adenoviral pneumonia requiring ECMO has been poor, and prolonged time on ECMO is associated with increased mortality. We present 2 pediatric cases of adenoviral pneumonia in patients who survived after greater than 30 days on ECMO and review the Extracorporeal Life Support Organization (ELSO) registry to describe the collective experience of children with viral pneumonia requiring prolonged ECMO. Although survival has improved over the past decade for pediatric adenoviral pneumonia, the ELSO database previously has had no surviving children reported with a primary diagnosis of adenovirus after more than 4 weeks on ECMO. Our experience suggests that there may be use for prolonged ECMO support in children despite severe adenoviral pneumonia.
Author List
Allibhai TF, Spinella PC, Meyer MT, Hall BH, Kofos D, DiGeronimo RJAuthor
Michael T. Meyer BS, MS, MD Chief, Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Adenovirus Infections, HumanAnti-Bacterial Agents
Child, Preschool
Extracorporeal Membrane Oxygenation
Female
Follow-Up Studies
Humans
Infant
Pneumonia, Viral
Risk Assessment
Severity of Illness Index
Time Factors
Treatment Outcome
Ventilator Weaning









